These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 30106193

  • 1. Domperidone for insufficient lactation in England 2002-2015: A drug utilization study with interrupted time series analysis.
    Mehrabadi A, Reynier P, Platt RW, Filion KB.
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1316-1324. PubMed ID: 30106193
    [Abstract] [Full Text] [Related]

  • 2. Off-label postpartum use of domperidone in Canada: a multidatabase cohort study.
    Moriello C, Paterson JM, Reynier P, Dahl M, Aibibula W, Fisher A, Gamble JM, Kuo IF, Ronksley PE, Winquist B, Filion KB, Canadian Network for Observational Drug Effect Studies (CNODES) Investigators.
    CMAJ Open; 2021 Dec; 9(2):E500-E509. PubMed ID: 33990364
    [Abstract] [Full Text] [Related]

  • 3. The association between domperidone and ventricular arrhythmia in the postpartum period.
    Smolina K, Mintzes B, Hanley GE, Oberlander TF, Morgan SG.
    Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1210-1214. PubMed ID: 27296864
    [Abstract] [Full Text] [Related]

  • 4. Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study.
    Arana A, Johannes CB, McQuay LJ, Varas-Lorenzo C, Fife D, Rothman KJ.
    Drug Saf; 2015 Dec; 38(12):1187-99. PubMed ID: 26350642
    [Abstract] [Full Text] [Related]

  • 5. Current use of domperidone and co-prescribing of medications that increase its arrhythmogenic potential among older adults: a population-based cohort study in Ontario, Canada.
    Rojas-Fernandez C, Stephenson AL, Fischer HD, Wang X, Mestre T, Hutson JR, Pondal M, Lee DS, Rochon PA, Marras C.
    Drugs Aging; 2014 Nov; 31(11):805-13. PubMed ID: 25227452
    [Abstract] [Full Text] [Related]

  • 6. Domperidone and long QT syndrome.
    Rossi M, Giorgi G.
    Curr Drug Saf; 2010 Jul 02; 5(3):257-62. PubMed ID: 20394569
    [Abstract] [Full Text] [Related]

  • 7. Factors associated with domperidone use as a galactogogue at an Australian tertiary teaching hospital.
    Grzeskowiak LE, Dalton JA, Fielder AL.
    J Hum Lact; 2015 May 02; 31(2):249-53. PubMed ID: 25355785
    [Abstract] [Full Text] [Related]

  • 8. [Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database].
    Rochoy M, Auffret M, Béné J, Gautier S, Réseau français des centres régionaux de pharmacovigilance.
    Rev Epidemiol Sante Publique; 2017 Feb 02; 65(1):1-8. PubMed ID: 27988172
    [Abstract] [Full Text] [Related]

  • 9. Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study.
    Chen HL, Hsiao FY.
    Pharmacoepidemiol Drug Saf; 2015 Aug 02; 24(8):841-8. PubMed ID: 26098410
    [Abstract] [Full Text] [Related]

  • 10. Estimating the number of sudden cardiac deaths attributable to the use of domperidone in France.
    Hill C, Nicot P, Piette C, Le Gleut K, Durand G, Toussaint B.
    Pharmacoepidemiol Drug Saf; 2015 May 02; 24(5):543-7. PubMed ID: 25832309
    [Abstract] [Full Text] [Related]

  • 11. Case report: domperidone use as a galactagogue resulting in withdrawal symptoms upon discontinuation.
    Doyle M, Grossman M.
    Arch Womens Ment Health; 2018 Aug 02; 21(4):461-463. PubMed ID: 29090362
    [Abstract] [Full Text] [Related]

  • 12. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands.
    van Noord C, Dieleman JP, van Herpen G, Verhamme K, Sturkenboom MC.
    Drug Saf; 2010 Nov 01; 33(11):1003-14. PubMed ID: 20925438
    [Abstract] [Full Text] [Related]

  • 13. Effect of European Medicines Agency's restrictions on trimetazidine utilization in Portugal.
    Pinto D, Silva A, Heleno B, Rodrigues DS, Santos I, Caetano PA.
    Pharmacoepidemiol Drug Saf; 2018 Sep 01; 27(9):962-968. PubMed ID: 29992780
    [Abstract] [Full Text] [Related]

  • 14. Media attention regarding sudden cardiac death associated with domperidone use does not affect in hospital ECG recording.
    Berger F, Saâïd S, van Gelder T, Stricker B, Becker M, van den Bemt P.
    Pharmacoepidemiol Drug Saf; 2017 Nov 01; 26(11):1418-1424. PubMed ID: 28924989
    [Abstract] [Full Text] [Related]

  • 15. Effects of domperidone on augmentation of lactation following cesarean delivery at full term.
    Jantarasaengaram S, Sreewapa P.
    Int J Gynaecol Obstet; 2012 Mar 01; 116(3):240-3. PubMed ID: 22189066
    [Abstract] [Full Text] [Related]

  • 16. Domperidone Prescribing Practices Exposed Patients to Cardiac Risk despite a "Black Box" Warning: A Canadian Tertiary Care Center Study.
    Forbes N, Cooray M, Al-Dabbagh R, Yuan Y, Tse F, Liu LW, Xenodemetropoulos T.
    Can J Gastroenterol Hepatol; 2016 Mar 01; 2016():2937678. PubMed ID: 27446835
    [Abstract] [Full Text] [Related]

  • 17. Low safety index of domperidone: mechanism for increased odds ratio for sudden cardiac death.
    Hondeghem LM.
    Acta Cardiol; 2011 Aug 01; 66(4):421-5. PubMed ID: 21894796
    [Abstract] [Full Text] [Related]

  • 18. Audit of domperidone use as a galactogogue at an Australian tertiary teaching hospital.
    Grzeskowiak LE, Lim SW, Thomas AE, Ritchie U, Gordon AL.
    J Hum Lact; 2013 Feb 01; 29(1):32-7. PubMed ID: 23015150
    [Abstract] [Full Text] [Related]

  • 19. Dose-effect study of domperidone as a galactagogue in preterm mothers with insufficient milk supply, and its transfer into milk.
    Wan EW, Davey K, Page-Sharp M, Hartmann PE, Simmer K, Ilett KF.
    Br J Clin Pharmacol; 2008 Aug 01; 66(2):283-9. PubMed ID: 18507654
    [Abstract] [Full Text] [Related]

  • 20. Increased risk of all-cause mortality associated with domperidone use in Parkinson's patients: a population-based cohort study in the UK.
    Simeonova M, de Vries F, Pouwels S, Driessen JHM, Leufkens HGM, Cadarette SM, Burden AM.
    Br J Clin Pharmacol; 2018 Nov 01; 84(11):2551-2561. PubMed ID: 29975795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.